Kathleen M. Brown
Kathleen M. Brown
V-Card
- BIOGRAPHY
- News
- Insights
Kathleen (“Kat”) Brown’s practice stretches across a broad range of areas in the highly regulated health care space.
Kat routinely assists clients in identifying and navigating potential regulatory pitfalls, including federal and state anti-referral laws, fee splitting and corporate practice of medicine (CPOM) laws, and HIPAA compliance and breach responses. She also counsels clients with questions related to licensure and practitioner scope of practice; pharmacy and wholesale distribution establishment and regulatory compliance; and pharmaceutical drug and device distribution chain questions. Kat also regularly performs health care diligence in large transactions, such as mergers and acquisitions.
Kat’s practice also involves working with nonprofits and charitable organizations at each phase of their lifecycle, from formation, application for federal tax exemption, and registration with state charities bureaus to day-to-day operations and ongoing corporate governance, including assisting organizations to implement policies to comply with their legal and fiduciary duties, inclusive of conflict of interest, whistleblower, and investment policies.
Prior to joining the firm, Kat developed her health care knowledge through her diverse experiences working in private practice, New York State government, government relations, and health care consulting. From that experience, Kat has developed a valuable understanding of the regulatory landscape impacting all provider types, enabling her to effectively and successfully advocate for her clients at all levels of government.
Garfunkel Wild attorneys have once again been selected by their peers for inclusion in the 2023 edition of Super Lawyers.
Thirty-Eight Garfunkel Wild attorneys were selected by their peers for inclusion in the 2024 editions of The Best Lawyers in America and The Best Lawyers: Ones to Watch.
Thirty-Three Garfunkel Wild attorneys were selected by their peers for inclusion in 2022 New York Metro Super Lawyers, and 2022 New York Metro/Upstate New York Rising Stars.
Thirty-Six Garfunkel Wild attorneys were selected by their peers for inclusion in 2021 New York Metro Super Lawyers, and 2021 New York Metro/Upstate New York Rising Stars.
Garfunkel Wild, P.C., a premier law firm with a specialty in health law, is pleased to announce the formal launch of the firm’s multi-disciplinary Cannabis Law Practice Group to help clients navigate the rapidly evolving cannabis landscape and conflicting federal, state, and local laws and regulations.
Thirty-Six Garfunkel Wild attorneys were selected by their peers for inclusion in 2020 New York Metro Super Lawyers, and 2020 New York Metro/Upstate Rising Stars.
Garfunkel Wild received prominent recognition in the 2025 editions of The Best Lawyers in America and The Best Lawyers in America: Ones to Watch. A total of 38 attorneys were honored with 59 individual recognitions across various practices and offices nationwide. Additionally, 3 Garfunkel Wild attorneys were distinguished as Lawyer of the Year, an accolade awarded to only one […]
Super Lawyers has recognized 36 Garfunkel Wild Attorneys across a range of the firm’s practice areas to the 2024 Super Lawyers and Rising Stars list.
Garfunkel Wild’s Stacey L. Gulick and Kathleen M. Brown will present the webinar “The Brave New World of Telehealth Post COVID - What You Need to Know ” on December 12, 2024, from 12:00 PM – 1:00 PM ET.
The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) have jointly issued a third emergency extension allowing health care practitioners to prescribe Schedule II-V controlled substances via audio-video telemedicine encounters without an initial in-person evaluation. This extension, effective from January 1, 2025 through December 31, 2025, also provides the DEA with additional time to finalize permanent regulations for prescribing controlled substances through telemedicine.
On October 12, 2024, the New York State Department of Health (“DOH”) published the final cybersecurity regulations for general hospitals (the “Regulations”), with some provisions effective immediately.
Andrew E. Blustein and Kathleen M. Brown will present "Compliance and Governance: Maintaining Operational Excellence for FQHCs" at the 2024 New Jersey Primary Care Association (“NJPCA”) Annual Conference, on October 10th.
On May 15, 2024, the New York State Department of Health (DOH) announced a pivotal change in its regulations, as it intends to permit health care providers to use telemedicine to conduct patient evaluations before prescribing controlled substances. Prior to the COVID-19 pandemic, DOH required health care providers to perform an initial in-person physical evaluation of patients before prescribing controlled substances.
The HIPAA Privacy Rule to Support Reproductive Health Care Privacy was recently announced as a final rule that becomes effective on June 25, 2024 (the “Final Rule”).
On March 9, 2024, CMS announced it will make available Change Healthcare/Optum Payment Disruption accelerated payments to providers experiencing potentially significant cash-flow problems as a result of the cyberattack on UnitedHealth Group’s subsidiary Change Healthcare/Optum .
Additional speaking & writing
Publications
- Authored chapters entitled “Immunizations” and “Issues Involving Infectious Diseases” in the Legal Manual for New York Physicians (Sixth Edition)
Kathleen (“Kat”) Brown’s practice stretches across a broad range of areas in the highly regulated health care space.
Kat routinely assists clients in identifying and navigating potential regulatory pitfalls, including federal and state anti-referral laws, fee splitting and corporate practice of medicine (CPOM) laws, and HIPAA compliance and breach responses. She also counsels clients with questions related to licensure and practitioner scope of practice; pharmacy and wholesale distribution establishment and regulatory compliance; and pharmaceutical drug and device distribution chain questions. Kat also regularly performs health care diligence in large transactions, such as mergers and acquisitions.
Kat’s practice also involves working with nonprofits and charitable organizations at each phase of their lifecycle, from formation, application for federal tax exemption, and registration with state charities bureaus to day-to-day operations and ongoing corporate governance, including assisting organizations to implement policies to comply with their legal and fiduciary duties, inclusive of conflict of interest, whistleblower, and investment policies.
Prior to joining the firm, Kat developed her health care knowledge through her diverse experiences working in private practice, New York State government, government relations, and health care consulting. From that experience, Kat has developed a valuable understanding of the regulatory landscape impacting all provider types, enabling her to effectively and successfully advocate for her clients at all levels of government.
On May 15, 2024, the New York State Department of Health (DOH) announced a pivotal change in its regulations, as it intends to permit health care providers to use telemedicine to conduct patient evaluations before prescribing controlled substances. Prior to the COVID-19 pandemic, DOH required health care providers to perform an initial in-person physical evaluation of patients before prescribing controlled substances.
The HIPAA Privacy Rule to Support Reproductive Health Care Privacy was recently announced as a final rule that becomes effective on June 25, 2024 (the “Final Rule”).
On March 9, 2024, CMS announced it will make available Change Healthcare/Optum Payment Disruption accelerated payments to providers experiencing potentially significant cash-flow problems as a result of the cyberattack on UnitedHealth Group’s subsidiary Change Healthcare/Optum .
Andrew E. Blustein and Kathleen M. Brown will present "Compliance and Governance: Maintaining Operational Excellence for FQHCs" at the 2024 New Jersey Primary Care Association (“NJPCA”) Annual Conference, on October 10th.
On October 12, 2024, the New York State Department of Health (“DOH”) published the final cybersecurity regulations for general hospitals (the “Regulations”), with some provisions effective immediately.
The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) have jointly issued a third emergency extension allowing health care practitioners to prescribe Schedule II-V controlled substances via audio-video telemedicine encounters without an initial in-person evaluation. This extension, effective from January 1, 2025 through December 31, 2025, also provides the DEA with additional time to finalize permanent regulations for prescribing controlled substances through telemedicine.
Garfunkel Wild’s Stacey L. Gulick and Kathleen M. Brown will present the webinar “The Brave New World of Telehealth Post COVID - What You Need to Know ” on December 12, 2024, from 12:00 PM – 1:00 PM ET.
Garfunkel Wild’s Stacey L. Gulick and Kathleen M. Brown will present the webinar “The Brave New World of Telehealth Post COVID - What You Need to Know ” on December 12, 2024, from 12:00 PM – 1:00 PM ET.
The Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) have jointly issued a third emergency extension allowing health care practitioners to prescribe Schedule II-V controlled substances via audio-video telemedicine encounters without an initial in-person evaluation. This extension, effective from January 1, 2025 through December 31, 2025, also provides the DEA with additional time to finalize permanent regulations for prescribing controlled substances through telemedicine.
On October 12, 2024, the New York State Department of Health (“DOH”) published the final cybersecurity regulations for general hospitals (the “Regulations”), with some provisions effective immediately.
Andrew E. Blustein and Kathleen M. Brown will present "Compliance and Governance: Maintaining Operational Excellence for FQHCs" at the 2024 New Jersey Primary Care Association (“NJPCA”) Annual Conference, on October 10th.
On May 15, 2024, the New York State Department of Health (DOH) announced a pivotal change in its regulations, as it intends to permit health care providers to use telemedicine to conduct patient evaluations before prescribing controlled substances. Prior to the COVID-19 pandemic, DOH required health care providers to perform an initial in-person physical evaluation of patients before prescribing controlled substances.
The HIPAA Privacy Rule to Support Reproductive Health Care Privacy was recently announced as a final rule that becomes effective on June 25, 2024 (the “Final Rule”).
On March 9, 2024, CMS announced it will make available Change Healthcare/Optum Payment Disruption accelerated payments to providers experiencing potentially significant cash-flow problems as a result of the cyberattack on UnitedHealth Group’s subsidiary Change Healthcare/Optum .
Additional speaking & writing
Publications
- Authored chapters entitled “Immunizations” and “Issues Involving Infectious Diseases” in the Legal Manual for New York Physicians (Sixth Edition)
Practices
Education
- cum laude
- Kate Stoneman Award, 2014
- Student Service Award, 2013
- cum laude, Criminal Justice
Court admissions
U.S. District Court: Northern District of New York
PROFESSIONAL MEMBERSHIPS
Women’s Bar Association of the State of New York (WBASNY); 2011 to present
Capital District Women’s Bar Association (CDWBA); 2011 to present
New York State Bar Association (NYSBA); 2011 to present
American Health Law Association
Committee on Character & Fitness, NYS Supreme Court, Appellate Division, 3rd Judicial Department
AWARDS & RANKINGS
Best Lawyers in America® Ones to Watch – Health Care Law (2024-2025)
Super Lawyers – Upstate New York Rising Star (2020-2024)